William DeVinney

Counsel

Washington, D.C.
T 202.861.1554  |  F 202.861.1783

William DeVinney has a broad litigation practice that includes antitrust, intellectual property, commercial class action, securities, and other complex commercial litigation. He has extensive trial experience, both as a member of trail teams and as first chair in jury and bench trials, arbitrations proceedings, and regulatory hearings. William has also argued cases before several federal and state appellate courts. He also counsels clients on antitrust issues.

Select Experience

  • Member of team representing certified class of dairy farmers located in 14 Southeastern States against Dairy Farmers of America, Dean Foods, and a number of other defendants in an action alleging violations of Sections 1 and 2 of the Sherman Act by unlawfully conspiring to eliminate competition for marketing, sale, and purchase of raw milk in the Southeast United States. Litigation was settled for more than 70 percent of alleged damages.
  • Represented multinational consumer goods company in consumer class action alleging false advertising. Complaint against client dismissed with prejudice.
  • Represented multinational chemical and agricultural biotechnology corporation against Sherman Act Section 2 claim brought by competitor alleging that client had either monopolized or attempted to monopolize alleged market for transgenic corn seed.
More »

Experience

  • Member of team representing certified class of dairy farmers located in 14 Southeastern States against Dairy Farmers of America, Dean Foods, and a number of other defendants in an action alleging violations of Sections 1 and 2 of the Sherman Act by unlawfully conspiring to eliminate competition for marketing, sale, and purchase of raw milk in the Southeast United States. Litigation was settled for more than 70 percent of alleged damages.
  • Represented multinational consumer goods company in consumer class action alleging false advertising. Complaint against client dismissed with prejudice.
  • Represented multinational chemical and agricultural biotechnology corporation against Sherman Act Section 2 claim brought by competitor alleging that client had either monopolized or attempted to monopolize alleged market for transgenic corn seed.
  • Defended multinational chemical and agricultural biotechnology company accused of monopolizing market for transgenic corn seed industry. Motion for class certification by plaintiff rejected by trial court and before Third Circuit on appeal.
  • Represented multinational technology company in private antitrust claim brought by competitor, as well as in investigations brought by the EU, Federal Trade Commission, and state government enforcement agencies.
  • Defended former executive of Bankers Trust Corporation in criminal trial and related SEC administrative proceedings arising from alleged improper accounting treatment of unclaimed funds. After six-week jury trial, client was acquitted of all 36 counts in indictment and favorable settlement was reached with SEC.

Pro Bono

  • Served as lead counsel for three congressmen and a public interest group filing amicus brief in United States Supreme Court.
  • Represented several clients in fair housing cases in antidiscrimination, fair housing, landlord/tenant, and contractual disputes.

Services

Admissions

  • U.S. Supreme Court
  • U.S. Court of Appeals, Federal Circuit
  • U.S. District Court, District of Columbia
  • U.S. District Court, Eastern District of New York
  • U.S. District Court, Southern District of New York
  • District of Columbia
  • New York

Education

  • J.D., William & Mary Law School, 1998
  • B.S., Cornell University, 1991

Blog

In The Blogs

Previous Next
Antitrust Advocate
Nominations Open for ABA Journal’s Top 100 Legal Blogs
July 29, 2014
The American Bar Association Journal announced that it is compiling its annual list of the 100 best legal blogs and invites readers to submit a nomination: Use the form below to tell us about a blog—not your own—that you read regularly and...
Read More ->
Antitrust Advocate
Buckle Up—Unwinding Phoebe Putney’s Acquisition of Palmyra Down in Georgia May End Up Being Back on the Table
July 22, 2014
Almost one year ago, Federal Trade Commission (FTC) agreed to settle its antitrust challenge of Phoebe Putney Health System’s (Phoebe Putney) acquisition of Palmyra Medical Center (Palmyra) without requiring divesture or any other remedial...
Read More ->
Antitrust Advocate
Don’t Pop the Cork Just Yet—Growing Criticism of Massachusetts AG’s Settlement with Partners Healthcare Just Might Send the Parties Back to the Drawing Board
July 22, 2014
After touting a proposed settlement with Partners HealthCare (Partners) that supposedly would “fundamentally alter [Partners’] negotiating power for 10 years and control health costs across [Partners’] entire network,” Massachusetts...
Read More ->
Antitrust Advocate
Let The Rejoicing Begin, Or Not—Massachusetts AG’s Settlement With Partners Healthcare Is No Harbinger of Things to Come
June 27, 2014
After almost half a dozen years of investigating Partners HealthCare’s (Partners) contracting practices and its proposed acquisitions of two competing hospital systems, Massachusetts Attorney General (AG) Martha Coakley announced a “final...
Read More ->
Antitrust Advocate
Leave My Employees Alone! You Promised You Wouldn’t Hire/Solicit Them
June 13, 2014
With the antitrust class action against Google, Apple, Intel and other Silicon Valley heavyweights nearly in the books ($300 million plus in settlements and millions more in defense fees later), it is time once again to ask what this...
Read More ->